Craig-Hallum Initiates Coverage On Pulmonx with Buy Rating, Announces Price Target of $18
Portfolio Pulse from Benzinga Newsdesk
Craig-Hallum analyst Alexander Nowak has initiated coverage on Pulmonx (NASDAQ:LUNG) with a Buy rating and a price target of $18.
September 05, 2023 | 12:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Pulmonx has received a Buy rating from Craig-Hallum with a price target of $18.
The Buy rating and price target set by Craig-Hallum indicates a positive outlook for Pulmonx. This could potentially attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100